Subscribe to RSS
DOI: 10.1055/s-0042-1743274
Incidence of Olfactory and Gustatory Dysfunctions in the Early Stages of COVID-19: An Objective Evaluation
Abstract
Introduction Coronavirus disease 2019 (COVID-19) is a dangerous infectious disease caused by a newly discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has various clinical presentations. Numerable cases with non-specific olfactory and gustatory dysfunctions in COVID-19 have been reported from all over the globe. This is important as awareness will let people to self-isolate and help in limiting disease spread.
Objective To objectively evaluate the frequency of olfactory and gustatory dysfunction, which may occur independently or with other symptoms, in laboratory confirmed COVID-19 patients at an early stage of the disease.
Methods Objective evaluation of olfactory and gustatory function of 322 COVID-19 patients treated at our hospital, (SMGS, Government Medical College, Jammu), from August 2020 until November 2020.
Results Our study population included 127 (39.4%) males and 195 (60.6%) females. Two hundred and twenty-six (70.2%) COVID-19 patients experienced olfactory and gustatory disorders. One hundred and sixty-five (51.2%) cases experienced both olfactory and gustatory disorders. Isolated olfactory dysfunction was reported in 34 (10.6%) patients, while 27 (8.4%) patients experienced only gustatory dysfunction.
Conclusion The olfactory and gustatory dysfunctions, without any nasal obstruction or rhinorrhea, are significant symptoms in the clinical presentation of early COVID-19 patients. This presentation can be recognized at the earliest one, and it can reduce the high communicability of the COVID-19 disease.
Publication History
Received: 25 April 2021
Accepted: 30 November 2021
Article published online:
20 May 2022
© 2022. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020; 24: 91-98 DOI: 10.1016/j.jare.2020.03.005.
- 2 Guan WJ, Ni ZY, Hu Y. et al; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720 DOI: 10.1056/NEJMoa2002032.
- 3 Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun 2020; 109: 102433 DOI: 10.1016/j.jaut.2020.102433.
- 4 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323 (13) 1239-1242 DOI: 10.1001/jama.2020.2648.
- 5 Zhou P, Yang XL, Wang XG. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579 (7798): 270-273 DOI: 10.1038/s41586-020-2012-7.
- 6 World health organisation. WHO Coronavirus disease (COVID-19) cases. . Published on 12 February 2021 http://www.who.int/data
- 7 Lovato A, de Filippis C, Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19). Am J Otolaryngol 2020; 41 (03) 102474 DOI: 10.1016/j.amjoto.2020.102474.
- 8 Lovato A, de Filippis C. Clinical presentation of COVID-19: a systematic review focusing on upper airway symptoms. Ear Nose Throat J 2020; 99 (09) 569-576 DOI: 10.1177/0145561320920762.
- 9 Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan China. Clin Infect Dis 2020; 71 (15) 769-777 DOI: 10.1093/cid/ciaa272.
- 10 Center for disease control and prevention. Coronavirus disease 2019 (COVID-19)-symptoms.. Published April 17, 2020 https://www.cdc.gov/coronavirus/2019-ncov/symptoms.html
- 11 Brann DH, Tsukahara T, Weinreb C. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci Adv 2020; 6 (31) eab5801 DOI: 10.1126/sciadv.abc5801.
- 12 Hopkins C, Surda P, Whitehead E, Kumar BN. Early recovery following new onset anosmia during the COVID-19 pandemic - an observational cohort study. J Otolaryngol Head Neck Surg 2020; 49 (01) 26 DOI: 10.1186/s40463-020-00423-8.
- 13 Xu H, Zhong L, Deng J. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020; 12 (01) 8 DOI: 10.1038/s41368-020-0074-x.
- 14 Bhuiyan MN, Ganesh R, Ghosh AK. COVID-19: A 2020 update. Indian J Med Sci 2020; 72 (02) 88-94 DOI: 10.25259/IJMS-123-2020.
- 15 George J, Jose T, Behari M. Use of Indian smell identification test for evaluating olfaction in idiopathic Parkinson's disease patients in India. Neurol India 2013; 61 (04) 365-370 DOI: 10.4103/0028-3886.117598.
- 16 Vaira LA, Salzano G, Petrocelli M, Deiana G, Salzano FA, De Riu G. Validation of a self-administered olfactory and gustatory test for the remotely evaluation of COVID-19 patients in home quarantine. Head Neck 2020; 42 (07) 1570-1576 DOI: 10.1002/hed.26228.
- 17 Hummel T, Landis BN, Hüttenbrink KB. Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg 2011; 10: Doc04 DOI: 10.3205/cto000077.
- 18 van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol 2015; 235 (02) 277-287 DOI: 10.1002/path.4461.
- 19 Ralli M, Di Stadio A, Greco A, de Vincentiis M, Polimeni A. Defining the burden of olfactory dysfunction in COVID-19 patients. Eur Rev Med Pharmacol Sci 2020; 24 (07) 3440-3441 DOI: 10.26355/eurrev-202004-20797.
- 20 Li K, Wohlford-Lenane C, Perlman S. et al. Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis 2016; 213 (05) 712-722 DOI: 10.1093/infdis/jiv499.
- 21 Matsuo R. Role of saliva in the maintenance of taste sensitivity. Crit Rev Oral Biol Med 2000; 11 (02) 216-229 DOI: 10.1177/10454411000110020501.
- 22 Liu L, Wei Q, Alvarez X. et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. J Virol 2011; 85 (08) 4025-4030 DOI: 10.1128/JVI.02292-10.
- 23 Dell'Era V, Farri F, Garzaro G, Gatto M, Aluffi Valletti P, Garzaro M. Smell and taste disorders during COVID-19 outbreak: Cross-sectional study on 355 patients. Head Neck 2020; 42 (07) 1591-1596 DOI: 10.1002/hed.26288.
- 24 Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol 2020; 10 (07) 806-813 DOI: 10.1002/alr.22579.
- 25 Lechien JR, Chiesa-Estomba CM, De Siati DR. et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol 2020; 277 (08) 2251-2261 DOI: 10.1007/s00405-020-05965-1.
- 26 Cao Y, Li L, Feng Z. et al. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov 2020; 6: 11 DOI: 10.1038/s41421-020-0147-1.
- 27 Li W, Zhang C, Sui J. et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J 2005; 24 (08) 1634-1643 DOI: 10.1038/sj.emboj.7600640.
- 28 Petrocelli M, Ruggiero F, Baietti AM. et al. Remote psychophysical evaluation of olfactory and gustatory functions in early-stage coronavirus disease 2019 patients: the Bologna experience of 300 cases. J Laryngol Otol 2020; 134 (07) 571-576 DOI: 10.1017/S0022215120001358.
- 29 Vaira LA, Deiana G, Fois AG. et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head Neck 2020; 42 (06) 1252-1258 DOI: 10.1002/hed.26204.
- 30 Chary E, Carsuzaa F, Trijolet JP. et al. Prevalance and recovery from olfactory and gustatory dysfunctions in Covid-19 infection: A prospective Multicentric study. Am J Rhinol Allergy 2020; 34 (05) 686-693 DOI: 10.1177/1945892420930954.
- 31 Lee Y, Min P, Lee S, Kim SW. Prevalance and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci 2020; 35 (18) e174 DOI: 10.3346/jkms.2020.35.e174.
- 32 Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients. J Infect 2020; 80 (06) e14-e18 DOI: 10.1016/j.jinf.2020.03.005.
- 33 Chen M, Shen W, Rowan NR. et al. Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur Respir J 2020; 56 (03) 2001948 , In press DOI: 10.1183/13993003.01948-2020.
- 34 Bunyavanich S, Do A, Vicencio A. Nasal gene expression of angiotensin converting enzyme 2 in children and adults. JAMA 2020; 323 (23) 2427-2429 DOI: 10.1001/jama.2020.8707.
- 35 Bilinska K, Jakubowska P, Von Bartheld CS, Butowt R. Expression of the SARS-CoV-2 entry proteins, ACE2 and TMPRSS2, in the cells of the olfactory epithelium: Identification of the cell types and trends with the age. ACS Chem Neurosci 2020; 11 (11) 1555-1562 DOI: 10.1021/acschemneuro.0c00210.